Share-based Payment Arrangement, Expense in USD of BioRestorative Therapies, Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioRestorative Therapies, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from 2011 to Q3 2025.
  • BioRestorative Therapies, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $399,932, a 41% increase year-over-year.
  • BioRestorative Therapies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $3,053,391, a 25% decline year-over-year.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2,812,566, a 64% decline from 2023.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7,782,967.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2013 was $647,815, a 43% decline from 2012.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BioRestorative Therapies, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,053,391 $399,932 +$115,687 +41% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,937,704 $468,708 +$144,386 +45% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $2,793,318 $2,009,126 -$19,248 -0.95% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $2,812,566 $175,625 -$1,249,475 -88% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $4,062,041 $284,245 -$1,209,459 -81% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $5,271,500 $324,322 -$1,161,346 -78% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $6,432,846 $2,028,374 -$1,350,121 -40% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $7,782,967 $1,425,100 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $1,493,704 -$1,580,824 -51% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,485,668 -$1,618,482 -52% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $3,378,495 +$2,592 +0.08% 01 Jan 2023 31 Mar 2023 10-Q 11 Jun 2024 2024 Q1
Q3 2022 $3,074,528 +$174,528 +6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $3,104,150 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $3,375,903 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $2,900,000 +$2,715,234 +1470% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q3 2020 $184,766 -$49,279 -21% 01 Jul 2020 30 Sep 2020 10-Q 12 Apr 2021 2020 Q3
Q2 2020 $219,264 -$223,540 -50% 01 Apr 2020 30 Jun 2020 10-Q 12 Apr 2021 2020 Q2
Q1 2020 $221,881 -$507,796 -70% 01 Jan 2020 31 Mar 2020 10-Q 29 Mar 2021 2020 Q1
Q3 2019 $234,045 01 Jul 2019 30 Sep 2019 10-Q 12 Apr 2021 2020 Q3
Q2 2019 $442,804 01 Apr 2019 30 Jun 2019 10-Q 12 Apr 2021 2020 Q2
Q1 2019 $729,677 01 Jan 2019 31 Mar 2019 10-Q 29 Mar 2021 2020 Q1
Q2 2015 $22,500 -$203,827 -90% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 $76,647 +$62,576 +445% 01 Jan 2015 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q2 2014 $226,327 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $14,071 -$168,536 -92% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $182,607 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1

BioRestorative Therapies, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,812,566 -$4,970,401 -64% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $7,782,967 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2013 $647,815 -$488,416 -43% 01 Jan 2013 31 Dec 2013 10-K 11 Apr 2014 2013 FY
2012 $1,136,231 +$1,012,331 +817% 01 Jan 2012 31 Dec 2012 10-K 11 Apr 2014 2013 FY
2011 $123,900 01 Jan 2011 31 Dec 2011 10-K 02 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.